Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 138

    1.

    HER-2/neu amplification testing in breast cancer by Multiplex Ligation-dependent Probe Amplification: influence of manual- and laser microdissection.

    Moelans CB, de Weger RA, Ezendam C, van Diest PJ.

    BMC Cancer. 2009 Jan 5;9:4.PMID: 19123950 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    HER-2/neu amplification testing in breast cancer by multiplex ligation-dependent probe amplification in comparison with immunohistochemistry and in situ hybridization.

    Moelans CB, de Weger RA, van Blokland MT, Ezendam C, Elshof S, Tilanus MG, van Diest PJ.

    Cell Oncol. 2009;31(1):1-10.PMID: 19096145 [PubMed - indexed for MEDLINE]Related articles

    3.

    Comparison of multiplex ligation dependent probe amplification to immunohistochemistry for assessing HER-2/neu amplification in invasive breast cancer.

    Purnomosari D, Aryandono T, Setiaji K, Nugraha SB, Pals G, van Diest PJ.

    Biotech Histochem. 2006 Mar-Jun;81(2-3):79-85.PMID: 16908432 [PubMed - indexed for MEDLINE]Related articles

    5.

    Assessment of HER-2/neu overexpression and/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice?

    Sauer T, Wiedswang G, Boudjema G, Christensen H, Karesen R.

    APMIS. 2003 Mar;111(3):444-50.PMID: 12752225 [PubMed - indexed for MEDLINE]Related articles

    6.

    Comparison of immunohistochemical and fluorescence in situ hybridization assessment for HER-2/neu status in Taiwanese breast cancer patients.

    Kuo SJ, Wang BB, Chang CS, Chen TH, Yeh KT, Lee DJ, Yin PL, Chen M.

    Taiwan J Obstet Gynecol. 2007 Jun;46(2):146-51.PMID: 17638622 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    HER-2 status in breast cancer: correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system.

    Ciampa A, Xu B, Ayata G, Baiyee D, Wallace J, Wertheimer M, Edmiston K, Khan A.

    Appl Immunohistochem Mol Morphol. 2006 Jun;14(2):132-7.PMID: 16785779 [PubMed - indexed for MEDLINE]Related articles

    9.

    HER-2/neu gene copy number quantified by real-time PCR: comparison of gene amplification, heterozygosity, and immunohistochemical status in breast cancer tissue.

    Königshoff M, Wilhelm J, Bohle RM, Pingoud A, Hahn M.

    Clin Chem. 2003 Feb;49(2):219-29.PMID: 12560343 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry.

    Pauletti G, Dandekar S, Rong H, Ramos L, Peng H, Seshadri R, Slamon DJ.

    J Clin Oncol. 2000 Nov 1;18(21):3651-64.PMID: 11054438 [PubMed - indexed for MEDLINE]Related articles

    11.

    Analysis of the HER2/neu gene amplification in microdissected breast cancer tumour samples.

    Seth RM, Burger AM, Kahn HJ.

    Anticancer Res. 2006 Mar-Apr;26(2A):927-31.PMID: 16619488 [PubMed - indexed for MEDLINE]Related articles

    12.

    Her-2/neu status in breast cancer metastases to the central nervous system.

    Lear-Kaul KC, Yoon HR, Kleinschmidt-DeMasters BK, McGavran L, Singh M.

    Arch Pathol Lab Med. 2003 Nov;127(11):1451-7.PMID: 14567724 [PubMed - indexed for MEDLINE]Related articles

    13.

    Simultaneous detection of TOP2A and HER2 gene amplification by multiplex ligation-dependent probe amplification in breast cancer.

    Moelans CB, de Weger RA, van Blokland MT, van der Wall E, van Diest PJ.

    Mod Pathol. 2009 Sep 18. [Epub ahead of print]PMID: 19767729 [PubMed - as supplied by publisher]Related articles

    14.

    The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.

    Latta EK, Tjan S, Parkes RK, O'Malley FP.

    Mod Pathol. 2002 Dec;15(12):1318-25.PMID: 12481013 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization.

    Lebeau A, Deimling D, Kaltz C, Sendelhofert A, Iff A, Luthardt B, Untch M, Löhrs U.

    J Clin Oncol. 2001 Jan 15;19(2):354-63.PMID: 11208826 [PubMed - indexed for MEDLINE]Related articles

    16.

    HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization.

    Perez EA, Roche PC, Jenkins RB, Reynolds CA, Halling KC, Ingle JN, Wold LE.

    Mayo Clin Proc. 2002 Feb;77(2):148-54.PMID: 11838648 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Chromogenic in situ hybridization (CISH): a novel alternative in screening archival breast cancer tissue samples for HER-2/neu status.

    Madrid MA, Lo RW.

    Breast Cancer Res. 2004;6(5):R593-600. Epub 2004 Jul 29.PMID: 15318940 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Her-2/neu gene amplification in low to moderately expressing breast cancers: possible role of chromosome 17/Her-2/neu polysomy.

    Bose S, Mohammed M, Shintaku P, Rao PN.

    Breast J. 2001 Sep-Oct;7(5):337-44.PMID: 11906444 [PubMed - indexed for MEDLINE]Related articles

    19.

    Comparison of HER-2/neu oncogene amplification detected by fluorescence in situ hybridization in lobular and ductal breast cancer.

    Rosenthal SI, Depowski PL, Sheehan CE, Ross JS.

    Appl Immunohistochem Mol Morphol. 2002 Mar;10(1):40-6.PMID: 11893034 [PubMed - indexed for MEDLINE]Related articles

    20.

    Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.

    Jimenez RE, Wallis T, Tabasczka P, Visscher DW.

    Mod Pathol. 2000 Jan;13(1):37-45.PMID: 10658908 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination